| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,260 |
9,100 |
$394K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,872 |
1,856 |
$144K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,374 |
1,366 |
$113K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,561 |
1,555 |
$112K |
| S8301 |
Infection control supplies, not otherwise specified |
7,212 |
6,477 |
$112K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,727 |
1,655 |
$94K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,660 |
3,160 |
$71K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
926 |
908 |
$66K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,235 |
2,160 |
$52K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,968 |
2,462 |
$40K |
| 99429 |
|
1,147 |
1,136 |
$39K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,413 |
4,178 |
$35K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,403 |
2,017 |
$20K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
844 |
806 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
443 |
440 |
$11K |
| 90461 |
|
1,765 |
1,485 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
550 |
544 |
$6K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
99 |
95 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
138 |
138 |
$4K |
| 0001A |
|
148 |
147 |
$4K |
| 83655 |
|
591 |
588 |
$4K |
| 97169 |
|
150 |
146 |
$4K |
| 0071A |
|
106 |
106 |
$3K |
| 96160 |
|
1,299 |
1,279 |
$2K |
| 0002A |
|
72 |
71 |
$2K |
| 0072A |
|
65 |
65 |
$2K |
| 97803 |
|
404 |
402 |
$1K |
| 87807 |
|
139 |
134 |
$910.80 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
54 |
34 |
$446.64 |
| 85018 |
|
197 |
197 |
$37.48 |
| 90661 |
|
22 |
22 |
$22.00 |
| 81003 |
|
16 |
16 |
$18.08 |
| 90686 |
|
1,327 |
1,319 |
$2.40 |
| 90681 |
|
109 |
108 |
$0.00 |
| 90670 |
|
637 |
626 |
$0.00 |
| 90734 |
|
322 |
319 |
$0.00 |
| 90633 |
|
359 |
355 |
$0.00 |
| 90671 |
|
164 |
163 |
$0.00 |
| 90707 |
|
28 |
28 |
$0.00 |
| 90710 |
|
71 |
71 |
$0.00 |
| 90700 |
|
28 |
28 |
$0.00 |
| 91300 |
|
233 |
207 |
$0.00 |
| 90715 |
|
101 |
101 |
$0.00 |
| 90648 |
|
15 |
15 |
$0.00 |
| 90697 |
|
70 |
67 |
$0.00 |
| 90698 |
|
233 |
233 |
$0.00 |
| 90651 |
|
469 |
467 |
$0.00 |
| 91307 |
|
211 |
198 |
$0.00 |
| 90696 |
|
56 |
56 |
$0.00 |
| 96127 |
|
626 |
615 |
$0.00 |
| 90688 |
|
38 |
37 |
$0.00 |
| 96161 |
|
26 |
26 |
$0.00 |
| 90677 |
|
45 |
43 |
$0.00 |
| 90744 |
|
45 |
45 |
$0.00 |
| 90656 |
|
21 |
21 |
$0.00 |
| 90716 |
|
30 |
30 |
$0.00 |
| 90620 |
|
15 |
15 |
$0.00 |